CAMBRIDGE, Mass. & BASEL, Switzerland & BEIJING–(BUSINESS WIRE)–BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today announced that the Company will participate in two upcoming investor conferences:
A live webcast can be accessed from the investors section of BeiGene’s websites at https://ir.beigene.com, https://hkexir.beigene.com and https://sseir.beigene.com. An archived replay will be available for 90 days following the event.
About BeiGene
BeiGene is a global biotechnology company that is developing and commercializing innovative and affordable oncology medicines to improve treatment outcomes and access for far more patients worldwide. With a broad portfolio, we are expediting development of our diverse pipeline of novel therapeutics through our internal capabilities and collaborations. We are committed to radically improving access to medicines for far more patients who need them. Our growing global team of more than 9,000 colleagues spans five continents, with administrative offices in Beijing, China; Cambridge, U.S.; and Basel, Switzerland. To learn more about BeiGene, please visit www.beigene.com and follow us on Twitter at @BeiGeneGlobal.
Contacts
Investor
Kevin Mannix
+1-857-302-5189
ir@beigene.com
Media
Kyle Blankenship
+1 667-351-5176
media@beigene.com
Key takeaways:The 2026 Ballon d'Or has no winner yet; the ceremony is still upcoming and…
Key takeaways:The Jio Platforms IPO allotment is being finalized ahead of the October 28 listing…
Key takeaways:The Jio IPO grey market premium was quoted at ₹245, with the issue 7.01…
Key takeaways:Jio Platforms IPO allotment status can be checked on the NSE, BSE and KFin…
Key takeaways:Andriy Lunin is Real Madrid's backup goalkeeper who started against Barcelona in El Clásico…
Key takeaways:Chef Damu (K. Damodaran), acclaimed Tamil chef and Padma Shri recipient, passed away at…